Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, nausea on Wegovy is most noticeable in the first few weeks of treatment and tends to ease as the body adjusts. Clinical trial data show that gastrointestinal side effects like nausea are most common early on, particularly after a dose increase, and generally settle within days to a couple of weeks. They rarely persist at the same intensity throughout treatment. These are prescription-only medicines, and a clinician reviews your full picture before any dose is started or changed — your experience is always monitored, not left to chance. If you're wondering exactly when nausea tends to begin after a first injection, the timing pattern is worth understanding before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phase 3 STEP 1 trial, published in the New England Journal of Medicine, is the core evidence base for semaglutide 2.4mg. Nausea was the most frequently reported adverse event among participants taking semaglutide, recorded in roughly 44% of that group compared with about 16% of those on placebo. That sounds stark. The figure that gets less attention is that the vast majority of those cases were graded mild to moderate, and most did not lead to people stopping treatment.
Crucially, the trial data show a time pattern rather than a flat line. Gastrointestinal events clustered around the early weeks of each dose step, then declined. By the later stages of the 68-week trial, rates in the semaglutide group had fallen considerably and were closer to placebo. So the nausea burden in week two of the starting dose is not a preview of month twelve. That distinction matters, and it is one our prescribers at nume (sorry, at nume) regularly explain to people nervous about committing to treatment.
The NHS semaglutide medicines page reflects this by describing nausea as common but typically settling after the first few weeks. That language is deliberate. It does not say nausea disappears overnight; it does not say it lasts for months. The honest middle ground is: most people notice it most in the first two weeks of any given dose, and it generally softens as the weeks pass.
Semaglutide slows gastric emptying, meaning food moves from the stomach into the small intestine more gradually than usual. That is part of how it reduces appetite and helps with portion control. The side effect of that mechanism, especially at first, is that the stomach feels fuller for longer and sometimes unsettled. The body does adapt, but adaptation takes time, typically days to a couple of weeks at each dose level.
The titration schedule used for Wegovy, which starts at 0.25mg and steps up roughly every four weeks, is structured this way partly to give the body that adjustment window. Each increase can trigger a milder repeat of the early nausea, which is why people sometimes feel they have turned a corner only to feel queasy again after moving up a dose. That is normal and expected, not a sign something has gone wrong. If you are wondering how long it takes to feel the effects of Wegovy at each stage, including when the nausea typically settles, that can help set realistic expectations.
Practical factors influence how pronounced nausea feels. Eating large meals, high-fat foods or eating quickly tend to worsen it. Many people find that smaller portions, slower eating and avoiding rich foods in the first week of each new dose make a noticeable difference. Hydration matters too, nausea from mild dehydration can compound what is already there. None of this is medical advice for your specific situation; your prescriber and the Patient Information Leaflet are the right guides for managing symptoms.
There is a misconception worth addressing gently: that any stomach discomfort on Wegovy is just the medicine doing its job and will pass. Most of the time, that is true. But there is one symptom pattern that should not be waited out. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, though infrequent, serious side effect of GLP-1 medicines including semaglutide. The signal to act is severe, persistent stomach pain (particularly pain that radiates to the back) with or without vomiting. That is not ordinary treatment nausea, and it needs same-day medical assessment, not a glass of water and a lie-down.
Persistent vomiting severe enough to prevent keeping fluids down is also a reason to contact a clinician, because dehydration can affect kidney function. The MHRA's Yellow Card scheme is the reporting route for any suspected serious side effect, and patients on Wegovy can use it directly. If you have questions about how to read your own symptoms, our team is available seven days a week for aftercare support.
Nausea on Wegovy is real and common, especially early on. For most people it is manageable rather than debilitating, and it eases as treatment continues. The titration structure exists specifically to minimise it. People often ask how quickly you feel Wegovy working, and a related question we hear just as often is how long it takes before Wegovy starts to feel different, because understanding that the nausea often arrives first, with the meaningful results coming later, puts the early discomfort in perspective.
If you are weighing the practicalities of starting, including what treatment costs and what is included in the price of a private prescription service, our Wegovy pricing page lays that out plainly. And if you want to look at how Wegovy fits alongside other licensed weight-loss options, our treatment overview covers the full picture. Wegovy is a prescription-only medicine; a clinician assesses suitability individually, taking into account your health history, any other medicines you take and your specific circumstances. Patients sometimes search for how long it takes to feel Wegovy before deciding whether to commit, and when you're ready to take that step, starting a free consultation puts your answers in front of a GPhC-registered prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.